With the support of
Project PCPP2022-009650 funded by Ministerio de Ciencia e Innovación – Agencia Estatal de Investigación, MICINN-AEI/10.13039/501100011033 and the European Union-NextGenerationEU/PRTR.
PROCELL aims at providing innovative tools and advanced methods to contribute to the progress of the Gene Therapy field. PROCELL will develop a novel lentiviral Production Cell System (ProCell) for optimized Gene Therapy manufacturing and implement scaled and GMP compliant methods for plasmid DNA production to overcome the current and future demand challenges the sector is confronting. PROCELL will position Gene Vector at the forefront of biotechnological companies in the Gene Therapy field adapting first to expected market demands.
Gene Vector Barcelona S.L.
C/ de Pallars, 179-185
08005, Barcelona
© 2024 GENE VECTOR BARCELONA S.L. All rights reserved.